Join
Live feed
·
PRReleasevia Quantisnow
Ardelyx Inc. logo

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

ByQuantisnow·Wall Street's wire, on your screen.
ARDX· Ardelyx Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARDX (Ardelyx Inc.) and more on Quantisnow.